Recently, attention mechanism and derived models have gained significant traction in drug
development due to their outstanding performance and interpretability in handling complex …

Antimicrobial resistance is a global public health threat, and the World Health Organization
(WHO) has announced a priority list of the most threatening pathogens against which novel …

Artificial intelligence (AI) is revolutionizing the current process of drug design and
development, addressing the challenges encountered in its various stages. By utilizing AI …

The healthcare sector is faced with challenges due to a shrinking healthcare workforce and
a rise in chronic diseases that are worsening with demographic and epidemiological shifts …

Abstract Structure‐based drug design is a widely applied approach in the discovery of new
lead compounds for known therapeutic targets. In most structure‐based drug design …

Synthetic binding proteins (SBPs) represent a pivotal class of artificially engineered proteins,
meticulously crafted to exhibit targeted binding properties and specific functions. Here, the …

Nanomedicine is a field of medicine that uses nanotechnology to develop new diagnostic
tools and therapies for a wide range of medical conditions. It encompasses a variety of …

Highlights A comprehensive review focused on the whole systems of the soft robotics with
artificial intelligence, which can feel, think, react and interact with humans, is presented. The …

The pharmaceutical sector has recently witnessed a transformative improvement and shift
toward artificial intelligence (AI) in its drug and pharmaceutical delivery process and …

Introduction The transition from conventional cytotoxic chemotherapy to targeted cancer
therapy with small-molecule anticancer drugs has enhanced treatment outcomes. This …